Antithrombin gamma + physiological saline
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Preeclampsia
Conditions
Preeclampsia
Trial Timeline
Nov 19, 2019 → Jun 16, 2023
NCT ID
NCT04182373About Antithrombin gamma + physiological saline
Antithrombin gamma + physiological saline is a phase 3 stage product being developed by Kyowa Kirin for Preeclampsia. The current trial status is completed. This product is registered under clinical trial identifier NCT04182373. Target conditions include Preeclampsia.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04182373 | Phase 3 | Completed |